65,437 trials
Hypertension
Primary: Change From Baseline at 8 Weeks in Seated Trough Cuff Mean Diastolic Blood Pressure (DBP) (Observed Telmisartan Effect) — -13; -16.4; -16.2; -16.9 mmHg
Acute Coronary Syndrome · Chest Pain
Primary: Cost of Index Hospitalization — 2062; 2680 US Dollars
Ankylosing Spondylitis
Primary: Number of Subjects With a Reduction in Signs and Symptoms as Measured by Assessments of Ankylosing Spondylitis (ASAS) 20 Response at Week 12 — 18; 12; 20; 32…
Type 2 Diabetes Mellitus
Primary: Area Under the Curve (AUC(0 to Infinity)) Following Single Dose Administration of the Anhydrous and Monohydrate Forms of MK0431 (Sitagliptin) — 8.38; 8.78 μmol*hr/L
Diabetes Mellitus, Type 2
Primary: Hemoglobin A1c (HbA1c) at 16 Week Endpoint — 7.71; 7.84 percent HbA1c — p=0.2519
Wrinkles in Frontal Area
Primary: Horizontal Action Halo Diameter at 28 Days — 1.28; 1.12 centimeter — p=<0.0001
Benign Prostatic Hyperplasia
Primary: Adverse Events — 431; 188; 29; 0 participants
Asthma
Primary: PC20 AMP (Post-treatment Compared to Baseline) — 4.9; 5.2; 3.7; 3.0 Logarithm (mg/mL)
Appendicitis · Cholecystitis · Diverticulitis
Primary: Number of Clinically Evaluable (CE) Patients With Clinical Response of Cure at the Test-of-Cure (TOC) Visit — 162; 150 participants
Infarction, Myocardial
Primary: Number of Participants With Complete Sum ST Resolution (STR) 60 Minutes (Min) After Percutaneous Coronary Intervention (PCI) (Per Protocol Population) — 71; 65…
Cutaneous T-cell Lymphoma
Primary: The Percent of Patients (Pts) With Objective Disease Response — 34 Percent of participants
Osteoarthritis, Knee · Pain
Primary: Change From Baseline of the Average Pain Intensity Based on an 11-point Numerical Rating Scale(NRS) Over the Last Week of the Maintenance Period at Week 12. — -3.0…
Arthralgia · Bunion · Hallux Valgus
Primary: Sum of Pain Intensity Difference Over 48 Hours (SPID48) — 54.1; 122.2; 143.7; 140.3 Scores on a scale — p=<0.001
Anemia, Sickle Cell
Primary: Time to Vaso-occlusive Pain Crisis (VOC) Resolution — 61.83; 55.16 Hours — p== 0.8085
Pulmonary Disease, Chronic Obstructive
Primary: Percentage of Participants Whose Post-albuterol Forced Expiratory Volume in One Second (FEV1) Was <80% Predicted Normal — 70; 30 percentage of participants